|
I claim the ornamental design for a nosepiece unit, as shown and described.
|
The broken lines of even length shown in the drawings illustrate portion of the nosepiece unit that form no part of the claimed design. The dash-dot-dash broken lines define the bounds of the claimed design and form no part of the claimed design.
Patent | Priority | Assignee | Title |
10076615, | Apr 05 2007 | OPTINOSE, INC | Nasal delivery |
10252010, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
10286164, | May 20 2003 | OPTINOSE, INC | Delivery device and method |
10398859, | Sep 15 2004 | OPTINOSE, INC | Nasal delivery devices |
10525218, | Nov 28 2006 | OPTINOSE, INC | Nasal delivery devices |
10525240, | Jun 28 2018 | Sandler Scientific LLC | Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system |
10639437, | Nov 28 2006 | OPTINOSE, INC | Delivery devices |
10639438, | Nov 28 2006 | OPTINOSE, INC | Delivery devices |
10722667, | Apr 05 2007 | OPTINOSE, INC | Nasal administration |
10737045, | Aug 28 2003 | OPTINOSE, INC | Delivery devices |
10765829, | Jul 25 2006 | OPTINOSE, INC | Delivery of gases to the nasal airway |
10864334, | Mar 23 2006 | OPTINOSE, INC | Nasal delivery |
11033696, | Feb 24 2012 | OPTINOSE, INC | Nasal delivery devices |
11083858, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
11571531, | Feb 23 2005 | OPTINOSE, INC | Powder delivery devices |
11602603, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
11690969, | Jul 25 2006 | OPTINOSE, INC | Delivery of gases to the nasal airway |
11707586, | Nov 19 2014 | OPTINOSE, INC | Intranasal administration |
11730904, | Nov 19 2014 | OPTINOSE, INC | Intranasal administration |
9949923, | Mar 15 2011 | OPTINOSE, INC | Nasal delivery |
D809128, | May 23 2013 | OPTINOSE, INC | Nosepiece unit |
ER1314, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Aug 05 2013 | DJUPESLAND, PER GISLE | Optinose, AS | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 037223 | /0918 | |
Feb 11 2015 | OptiNose AS | (assignment on the face of the patent) | / | |||
Dec 29 2017 | OptiNose AS | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 044976 | /0505 | |
Sep 12 2019 | OptiNose AS | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 050371 | /0913 | |
Sep 12 2019 | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | OptiNose AS | RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 | 050371 | /0894 | |
Mar 13 2023 | OptiNose AS | OPTINOSE, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 062974 | /0206 | |
Dec 10 2024 | OPTINOSE, INC | OPTINOSE, INC | CHANGE OF ADDRESS | 069825 | /0521 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |